Pancreatic Cancer Research

ResearcherShanghai University of Traditional Chinese MedicineNo recent work listed

Qingshan Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6235-8137; OpenAlex author ID A5077556517. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2023: 1 paper

Papers 1

  1. Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. Last author DOI 10.1200/jco.22.02630↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunyi Hao · 1 shared paper, 2023 · strength 0.13
  2. Tianshu Liu · 1 shared paper, 2023 · strength 0.13
  3. Ying Yuan · 1 shared paper, 2023 · strength 0.13
  4. Hongmei Zhang · 1 shared paper, 2023 · strength 0.13
  5. Lin Yang · 1 shared paper, 2023 · strength 0.13
  6. Lin Shen · 1 shared paper, 2023 · strength 0.13
  7. Jianming Xu · 1 shared paper, 2023 · strength 0.13
  8. Rui‐Hua Xu · 1 shared paper, 2023 · strength 0.13
  9. Jin Li · 1 shared paper, 2023 · strength 0.13
  10. Jun Zhang Zhang · 1 shared paper, 2023 · strength 0.13
  11. Shukui Qin · 1 shared paper, 2023 · strength 0.13
  12. Deliang Fu · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.